-transparent.png){kind=logo}
One of the most potent pro-inflammatory mediators is the early-acting cytokine interleukin-1. Its actions are regulated by a structurally related anti-inflammatory cytokine known as the interleukin-1 receptor antagonist. We have previously characterized a DNA polymorphism in this gene (IL-1rn) and have found associations between allele 2 and several chronic inflammatory diseases. In the present study, we tested the frequency of allele 2 of the IL-1rn gene in 90 patients with alopecia areata compared with 261 healthy controls. There was a significant association between allele 2 of the polymorphism and the severity of alopecia areata. The frequency of allele 2 increased from 24.1% in the control population to 25.9% in patchy alopecia areata, 36.1% in alopecia totalis, and 47.2% in alopecia universalis (p = 0.005). This severity association is similar to that found in other epithelial-related diseases, including inflammatory bowel disease, lichen sclerosus, and systemic lupus erythematosus.
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
February 2002,
The Journal of investigative dermatology,
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
May 2011,
Anesthesiology,
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
July 1996,
Journal of neuroimmunology,
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
November 2008,
Arquivos brasileiros de cardiologia,
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
October 2000,
Alcoholism, clinical and experimental research,
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
December 2001,
Rheumatology (Oxford, England),
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
June 2013,
Gene,
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
October 2005,
NeuroImage,
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
October 2003,
Annals of oncology : official journal of the European Society for Medical Oncology,
J K Tarlow, and
F E Clay, and
M J Cork, and
A I Blakemore, and
A J McDonagh, and
A G Messenger, and
G W Duff
February 2002,
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
